[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100503784":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":26,"centralContacts":31,"locations":37,"responsibleParty":55,"collaborators":26,"id":59,"slug":26,"hasResults":60,"nctId":61,"briefTitle":62,"officialTitle":63,"acronym":64,"eligibilityCriteria":65,"healthyVolunteers":60,"sex":66,"minAge":67,"maxAge":26,"enrollmentInfo":68,"targetDuration":26,"studyType":71,"phases":72,"briefSummary":74,"conditions":75,"keywords":26,"overallStatus":40,"whyStopped":26,"lastUpdateSubmitDate":78,"lastUpdatePostDateStruct":79,"startDateStruct":82,"completionDateStruct":84,"leadSponsor":86,"locationsCount":87},{"fullName":5,"class":6},"Mansoura University","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"control (C) group","PLACEBO_COMPARATOR","normal saline will be nebulized",[13],"Drug: normal saline",{"label":15,"type":16,"description":17,"interventionNames":18},"Budesonide (B) group","ACTIVE_COMPARATOR","budesonide will be nebulized",[19],"Drug: budesonide",[21,27],{"type":22,"name":23,"description":24,"armGroupLabels":25,"otherNames":26},"DRUG","budesonide","2 ml nebulized budesonide (containing 1 mg) diluted in 3 ml of normal saline will be nebulized preoperatively",[15],null,{"type":22,"name":28,"description":29,"armGroupLabels":30,"otherNames":26},"normal saline","5 ml normal saline will be nebulized preoperatively",[9],[32],{"name":33,"role":34,"phone":35,"phoneExt":26,"email":36},"Maha A AboZeid, MD","CONTACT","02-01019216192","mahazed@yahoo.com",[38],{"facility":39,"status":40,"city":41,"state":42,"zip":43,"country":44,"countryCode":45,"cosmosGeoPoint":46,"geoPoint":51,"contacts":52},"Maha Ahmed AboZeid","RECRUITING","Al Mansurah","Mansoura","35511","Egypt","EG",{"type":47,"coordinates":48},"Point",[49,50],31.38069,31.03637,{"lat":50,"lon":49},[53],{"name":54,"role":34,"phone":26,"phoneExt":26,"email":36},"Maha A AboZeid",{"type":56,"investigatorFullName":57,"investigatorTitle":58,"investigatorAffiliation":5,"oldNameTitle":26,"oldOrganization":26},"PRINCIPAL_INVESTIGATOR","maha abou-zeid","Assistant Professor of Anesthesia and Surgical Intensive Care","100503784",false,"NCT05839756","Predicting Post Extubation Stridor After Maxillomandibular Fixation","Predicting Post Extubation Stridor in Patients With Intermaxillary Fixation","airway","Inclusion Criteria:\n\n* Adult patients (\\>18 years)\n* American Society of Anesthesiologists status I and II\n* undergoing elective maxillomandibular fixation surgeries under general anesthesia with nasal endotracheal intubation\n\nExclusion Criteria:\n\n* patients' refusal\n* pregnant females\n* patients with body mass index \\\u003C18.5 or ≥ 35 kg\u002Fm2\n* risk of aspiration\n* cardiorespiratory disorder\n* neuromuscular disease\n* uncontrolled diabetes mellitus\n* gastrointestinal bleeding\n* on chronic steroid therapy\n* intubated patients or were intubated or had upper airway infection within 1 week prior to surgery\n* history of any pathology, radiotherapy or surgery in the neck\n* had difficult laryngeal US plane (as neck wound)","ALL","18 Years",{"count":69,"type":70},62,"ESTIMATED","INTERVENTIONAL",[73],"NA","Endotracheal intubation can induce laryngotracheal injury which results in narrowing of the airway due to edema of the glottis. This can increase the risk of development of post-extubation stridor (PES)",[76,77],"Stridor","Larynx Edema","2026-02-15",{"date":80,"type":81},"2026-02-17","ACTUAL",{"date":83,"type":81},"2023-05-03",{"date":85,"type":70},"2028-06-30",{"name":5,"class":6},1]